Delivery Order SPE2DR25D1017-SPE2DR26F9CVC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,885.46 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on December 11, 2025, with completion scheduled for December 12, 2025. This firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The contract was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $24,148.65 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pens on November 18, 2025, with a completion date of November 19, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location and supports the military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,269.43 to supply Zepbound 10 mg/0.5 mL pens on a firm fixed price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by November 4, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will perform this work through its role as a critical pharmaceutical distributor supporting federal medical procurement needs. This...
- The Defense Logistics Agency awarded a delivery order valued at $28,845.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $6,444.35 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pens in 0.5 mL doses, with an ultimate completion date of December 31, 2025. This contract utilizes firm fixed-price pricing with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $12,870.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Defense Logistics Agency contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $13,402.26 delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen (0.5 mL) with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, specifically supporting the military and veteran healthcare systems...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,109.73 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen medication, with a completion date of November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The product will be delivered to the company's corporate office location in...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CVCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,328.59 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen (0.5 ml) with a completion date of January 9, 2026. This non-set-aside contract was awarded on a firm fixed-price basis and represents a competitively awarded delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), maintains a comprehensive IDC with the Defense Logistics Agency valued up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates significant capability in delivering specialized medications, including diabetes treatments and other therapeutic products, across the military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 1/7/26 |